Where does EYE Therapies Llc rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), EYE Therapies Llc ranks #24,314 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does EYE Therapies Llc hold?

EYE Therapies Llc holds 11 US utility patents granted between 2015 and 2025, spanning 2 technology areas.

What is EYE Therapies Llc's Innovation Score?

EYE Therapies Llc has an Innovation Score of 41.8 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is EYE Therapies Llc's patent grant rate increasing or decreasing?

EYE Therapies Llc's recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for EYE Therapies Llc's patents?

EYE Therapies Llc's patents average 13.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the EYE Therapies Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

EYE Therapies Llc

Q: What technology areas does EYE Therapies Llc focus on?

EYE Therapies Llc's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 11 patents. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 2 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, EYE ranks #24,314 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 2 technology areas.

#24,314
of 50,000 US assignees by volume: Top 32%
by Innovation Score (41.8/100): 13.7
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24314 · US Corporation #24,314 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,314/50,000
PHOTO-FINISH Eagle Biologics
CPC-NARROW A61K · 2 areas
INNOV-PAR 41.8/100
CLAIMS-RICH 13.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Eagle Biologics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
EYE Therapies · this assignee

42
3D Lighting Innovati… · lowest

7

What this shows EYE's Innovation Score is 41.8/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where EYE's grants concentrate

EYE Therapies Llc is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2016. By volume, EYE sits between Exatec, Llc and East Penn Manufacturing Co..

EYE's three-year grant acceleration

EYE Therapies Llc shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Exatec

11
Excel-lens

11
Excellence Optoel…

11
Extron

11
Ezisurg Medical

11
Eagle Biologics

11
Earth Science Lab…

11
East Penn Manufac…

11
EYE Therapies ◀

11

What this shows EYE holds 11 patents at rank #24,265, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near EYE

By rank, the assignees closest to #24,265 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in EYE's primary technology class.

EYE's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

EYE Therapies Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	18.2%
2016	1	9.1%
2021	1	9.1%
2023	3	27.3%
2024	2	18.2%
2025partial year	2	18.2%

Which technologies does EYE Therapies Llc patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 11

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 10

Top 2 of 2 technology areas

Where it ranks

Overall rank by patents

#24,314

of 50,000 tracked assignees

Innovation Score

41.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.